These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38493324)
1. CHA2DS2-VASc Score as a Predictor of Adverse Outcomes after Ischemic Stroke in Patients without Atrial Fibrillation. Aker A; Volis I; Saliba W; Naoum I; Zafrir B Isr Med Assoc J; 2024 Mar; 26(3):143-148. PubMed ID: 38493324 [TBL] [Abstract][Full Text] [Related]
2. CHA2DS2-VASc score as a prognostic indicator in patients with atrial fibrillation undergoing coronary stenting. Zheng JY; Li DT; Qıu YG; Huang YX; Xu ZM; Zhao L; Chen Y; Cao Y; Tang YD; Guo CJ; Ma ZM; Wu YQ; Jıao Y; Li TC Turk J Med Sci; 2022 Aug; 52(4):1103-1110. PubMed ID: 36326398 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
4. CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke. Su CH; Lo CH; Chen HH; Tsai CF; Yip HT; Hsu KC; Hsu CY; Kao CH; PLoS One; 2022; 17(7):e0270823. PubMed ID: 35830440 [TBL] [Abstract][Full Text] [Related]
5. CHA Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320 [TBL] [Abstract][Full Text] [Related]
6. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. Chao TF; Lip GYH; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA J Am Coll Cardiol; 2018 Jan; 71(2):122-132. PubMed ID: 29325634 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980 [TBL] [Abstract][Full Text] [Related]
8. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
10. Use of the CHA Chua SK; Huang PS; Chen JJ; Chiu FC; Hwang JJ; Tsai CT Hellenic J Cardiol; 2024; 78():42-49. PubMed ID: 37633490 [TBL] [Abstract][Full Text] [Related]
11. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
12. Role of Cardiac Risk Scores in Clinical Use to Predict Outcomes of Acute Ischemic Stroke. Ozcan S; Donmez E; Coban E; Korkut E; Ziyrek M; Sahin I; Okuyan E Neurol India; 2023; 71(6):1197-1204. PubMed ID: 38174458 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726 [TBL] [Abstract][Full Text] [Related]
14. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention. Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143 [TBL] [Abstract][Full Text] [Related]
15. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting. Zheng JY; Cao Y; Li DT; Qiu YG; Zhao L; Xu ZM; Huang YX; Hong ZB; Li TC; Tang YD; Guo CJ; Ma ZM; Wu YQ; Chen Y Acta Cardiol; 2022 Jun; 77(4):360-365. PubMed ID: 34353224 [TBL] [Abstract][Full Text] [Related]
16. CHA Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228 [TBL] [Abstract][Full Text] [Related]
17. Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA Bel-Ange A; Itskovich SZ; Avivi L; Stav K; Efrati S; Beberashvili I BMC Nephrol; 2021 May; 22(1):179. PubMed ID: 33992086 [TBL] [Abstract][Full Text] [Related]
18. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422 [TBL] [Abstract][Full Text] [Related]
19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
20. CHA Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]